专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2010150281A3 NOVEL AZABICYCLOHEXANES 审中-公开
标题翻译：新的雅各布
公开(公告)号：WO2010150281A3
公开(公告)日：2011-04-21
申请号：PCT/IN2010000428
申请日：2010-06-22
申请人： PANACEA BIOTEC LTD , JAIN RAJESH , TREHAN SANJAY , DAS JAGATTARAN , KAUR GURMEET , KANWAR SANDEEP , SINGH NISHAN , NANDA GURMEET KAUR , MAGADI SITARAM KUMAR , SHARMA SUDHIR KUMAR
发明人： JAIN RAJESH , TREHAN SANJAY , DAS JAGATTARAN , KAUR GURMEET , KANWAR SANDEEP , SINGH NISHAN , NANDA GURMEET KAUR , MAGADI SITARAM KUMAR , SHARMA SUDHIR KUMAR
IPC分类号： C07D221/22 , A61K31/46 , A61K31/496 , A61K31/498 , A61K31/5355 , A61K31/551 , A61P25/00 , A61P31/00 , C07D401/10 , C07D413/10 , C07D413/14 , C07D417/10 , C07D471/04 , C07D487/04 , C07D491/08
CPC分类号： C07D221/22 , C07D209/52 , C07D401/10 , C07D409/04 , C07D413/10 , C07D413/14 , C07D417/10 , C07D417/14 , C07D471/04 , C07D487/04 , C07D491/08
摘要： The present invention relates to novel compounds of Formula (I), their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof.
摘要翻译：本发明涉及式（I）的新化合物，其药学上可接受的衍生物，互变异构体，立体异构体，包括R和S异构体，多晶型物，前药，代谢物，盐或溶剂化物。本发明还涉及合成式I的新化合物，其药学上可接受的衍生物，互变异构体形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂合物的方法。

2. 发明申请

WO2009093269A1 NOVEL HETEROCYCLIC COMPOUNDS 审中-公开
标题翻译：新型杂环化合物
公开(公告)号：WO2009093269A1
公开(公告)日：2009-07-30
申请号：PCT/IN2009000061
申请日：2009-01-23
申请人： PANACEA BIOTEC LTD , JAIN RAJESH , TREHAN SANJAY , SINGH NISHAN , NANDA GURMEET KAUR , MAGADI SITARAM KUMAR , SHARMA SUDHIR KUMAR , DAS JAGATTARAN
发明人： JAIN RAJESH , TREHAN SANJAY , SINGH NISHAN , NANDA GURMEET KAUR , MAGADI SITARAM KUMAR , SHARMA SUDHIR KUMAR , DAS JAGATTARAN
IPC分类号： C07D243/14 , A61K31/551 , A61P3/10 , C07D403/06 , C07D413/12 , C07D487/04
CPC分类号： C07D243/14 , C07D403/06 , C07D413/12 , C07D487/04
摘要： The present invention relates to novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising compounds of Formula I and methods of treating or preventing one or more conditions that may be regulated or normalized via inhibition of dipeptidyl peptidase IV (DPP-IV). Formula I
摘要翻译：本发明涉及式I的新化合物，其药学上可接受的衍生物，互变异构形式，包括R和S异构体在内的立体异构体，多晶型物，前药，代谢物，盐或溶剂化物。本发明还涉及用于合成式I的新化合物，其药学上可接受的衍生物，互变异构形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂合物的方法。本发明还提供了包含式I化合物的药物组合物以及治疗或预防一种或多种可通过抑制二肽基肽酶IV（DPP-IV）而调节或正常化的条件的方法。公式I

3. 发明申请

WO2011070592A2 NOVEL SUGAR DERIVATIVES 审中-公开
标题翻译：新糖衍生物
公开(公告)号：WO2011070592A2
公开(公告)日：2011-06-16
申请号：PCT/IN2010000796
申请日：2010-12-09
申请人： PANACEA BIOTEC LTD , JAIN RAJESH , TREHAN SANJAY , THUNGATHURTHI SASTRY V R S , NANDA GURMEET KAUR , DAS JAGATTARAN , MAGADI SITARAM KUMAR , SHARMA SUDHIR KUMAR
发明人： JAIN RAJESH , TREHAN SANJAY , THUNGATHURTHI SASTRY V R S , NANDA GURMEET KAUR , DAS JAGATTARAN , MAGADI SITARAM KUMAR , SHARMA SUDHIR KUMAR
CPC分类号： C07H15/04 , C07D309/10
摘要： The present invention relates to novel compounds of Formula (I), their pharmaceutically acceptable derivatives, analogs, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, analogs, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of Formula I and methods of treating or preventing one or more conditions or diseases that may be regulated or normalized via inhibition of Sodium Glucose Cotransporter-2 (SGLT-2). The invention also relates to the use of compounds of Formula I, their pharmaceutically acceptable derivatives, analogs, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof, for the manufacture of a medicament for the prophylaxis, amelioration and/or treatment of conditions or diseases that may be regulated or normalized via inhibition of Sodium Glucose Cotransporter-2 (SGLT-2) and the related diseases, disorders and conditions, in a subject in need thereof.
摘要翻译：本发明涉及式（I）的新化合物，其药学上可接受的衍生物，类似物，互变异构形式，异构体，多晶型物，前药，代谢物，盐或溶剂合物。本发明还涉及合成式I的新化合物，其药学上可接受的衍生物，类似物，互变异构形式，异构体，多晶型物，前药，代谢物，盐或溶剂合物的方法。本发明还提供包含式I的新化合物和治疗或预防一种或多种可通过抑制葡萄糖转运蛋白-2（SGLT-2）调节或归一化的病症或疾病的药物组合物。本发明还涉及式I化合物，其药学上可接受的衍生物，类似物，互变异构体形式，异构体，多晶型物，前体药物，代谢物，盐或溶剂合物在制备用于预防和/或改善在有需要的受试者中通过抑制葡萄糖转运蛋白-2（SGLT-2）和相关疾病，病症和病症来调节或归一化的病症或疾病的治疗。

4. 发明申请

WO2010058423A3 NOVEL ANTIMICROBIALS 审中-公开
标题翻译：新的抗生素
公开(公告)号：WO2010058423A3
公开(公告)日：2010-12-09
申请号：PCT/IN2009000658
申请日：2009-11-18
申请人： PANACEA BIOTEC LTD , JAIN RAJESH , TREHAN SANJAY , DAS JAGATTARAN , KANWAR SANDEEP , MAGADI SITARAM KUMAR , SHARMA SUDHIR KUMAR
发明人： JAIN RAJESH , TREHAN SANJAY , DAS JAGATTARAN , KANWAR SANDEEP , MAGADI SITARAM KUMAR , SHARMA SUDHIR KUMAR
IPC分类号： C07D413/10 , C07D413/14
CPC分类号： C07D487/04 , C07D263/20 , C07D413/12 , C07D413/14 , C07D417/12
摘要： The present invention relates to novel phenyl oxazolidinone compounds of formula I, their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of formula I or their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of formula I and methods of using them. The compounds of the present invention are useful as antimicrobial agents, effective against a number of aerobic and/or anaerobic Gram positive and/or Gram negative pathogens such as multi drug resistant species of Staphylococcus, Streptococcus, Enterococcus, Bacterioides, Clostridia, H. influenza, Moraxella, acid-fast organisms such as Mycobacterium tuberculosis as well as Linezolid resistant species of Staphylococcus and Enterococcus.
摘要翻译：本发明涉及式I的新型苯基恶唑烷酮化合物，其药学上可接受的类似物，互变异构形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂化物。本发明还涉及合成新型式I化合物或其药学上可接受的类似物，互变异构体形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂合物的方法。本发明还提供了包含新颖的式I化合物和使用它们的方法的药物组合物。本发明的化合物可用作抗微生物剂，对许多需氧和/或厌氧革兰氏阳性和/或革兰氏阴性病原体有效，如葡萄球菌，链球菌，肠球菌，细菌，梭菌，流感嗜血杆菌，莫拉氏菌，耐酸菌，如结核分枝杆菌，以及耐盐霉菌属的霉菌和肠球菌。

5. 发明申请

WO2010058423A2 NOVEL ANTIMICROBIALS 审中-公开
标题翻译：新的抗微生物剂
公开(公告)号：WO2010058423A2
公开(公告)日：2010-05-27
申请号：PCT/IN2009000658
申请日：2009-11-18
申请人： PANACEA BIOTEC LTD , JAIN RAJESH , TREHAN SANJAY , DAS JAGATTARAN , KANWAR SANDEEP , MAGADI SITARAM KUMAR , SHARMA SUDHIR KUMAR
发明人： JAIN RAJESH , TREHAN SANJAY , DAS JAGATTARAN , KANWAR SANDEEP , MAGADI SITARAM KUMAR , SHARMA SUDHIR KUMAR
IPC分类号： C07D413/10 , C07D413/14
CPC分类号： C07D487/04 , C07D263/20 , C07D413/12 , C07D413/14 , C07D417/12
摘要： The present invention relates to novel phenyl oxazolidinone compounds of formula I, their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of formula I or their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of formula I and methods of using them. The compounds of the present invention are useful as antimicrobial agents, effective against a number of aerobic and/or anaerobic Gram positive and/or Gram negative pathogens such as multi drug resistant species of Staphylococcus, Streptococcus, Enterococcus, Bacterioides, Clostridia, H. influenza, Moraxella, acid-fast organisms such as Mycobacterium tuberculosis as well as Linezolid resistant species of Staphylococcus and Enterococcus.
摘要翻译：本发明涉及式I的新型苯基恶唑烷酮化合物，其药学上可接受的类似物，互变异构形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂化物。本发明还涉及合成式I的新化合物或其药学上可接受的类似物，互变异构形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂合物的方法。本发明还提供了包含新型式I化合物和使用它们的方法的药物组合物。本发明化合物可用作抗微生物剂，有效对抗许多需氧和/或厌氧革兰氏阳性和/或革兰氏阴性病原体，例如葡萄球菌，链球菌，肠球菌，细菌，梭菌，流感嗜血菌，莫拉菌属（Moraxella），耐酸生物体如结核分枝杆菌（Mycobacterium tuberculosis）以及耐利奈唑胺菌（Staphylococcus and Enterococcus）。

6. 发明申请

WO2009118765A3 NOVEL MONOAMINE RE-UPTAKE INHIBITOR 审中-公开
标题翻译：新型单体反应抑制剂
公开(公告)号：WO2009118765A3
公开(公告)日：2010-10-28
申请号：PCT/IN2009000202
申请日：2009-03-27
申请人： PANACEA BIOTEC LTD , KESSAR SATINDER VIR , KULKARNI SHRINIVAS KRISHNARAO , JAIN RAJESH , TREHAN SANJAY , MAGADI SITARAM KUMAR , DAS JAGATTARAN , KAUR GURMEET , SINGH KAMAL NAIN , LATA SNEH , DHIR ASHISH
发明人： KESSAR SATINDER VIR , KULKARNI SHRINIVAS KRISHNARAO , JAIN RAJESH , TREHAN SANJAY , MAGADI SITARAM KUMAR , DAS JAGATTARAN , KAUR GURMEET , SINGH KAMAL NAIN , LATA SNEH , DHIR ASHISH
IPC分类号： C07D217/16 , C07D401/04 , C07D401/06 , C07D405/04 , C07D409/04 , C07D409/06 , C07D411/12 , C07D413/12
CPC分类号： C07D217/16 , C07D401/04 , C07D401/06 , C07D405/04 , C07D409/04 , C07D409/06 , C07D411/12 , C07D413/12
摘要： The present invention relates to novel compounds of Formula (I), their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of Formula (I), their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention further provides pharmaceutical compositions comprising compounds of Formula (I) and methods of treating or preventing one or more disorders of the central and/or peripheral nervous system that are responsive to inhibition of biogenic amines, in particular one or more, or any combination of serotonin, norepinephrine and dopamine.
摘要翻译：本发明涉及式（I）的新化合物，其药学上可接受的衍生物，互变异构体，立体异构体，包括R和S异构体，多晶型物，前药，代谢物，盐或溶剂化物。本发明还涉及合成式（I）的新化合物，其药学上可接受的衍生物，互变异构体形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂合物的方法。本发明进一步提供药物组合物，其包含式（I）化合物和治疗或预防中枢和/或周围神经系统的一种或多种疾病，所述疾病对抑制生物胺特别是一种或多种或任何 5-羟色胺，去甲肾上腺素和多巴胺的组合。

7. 发明申请

WO2009118765A8 NOVEL MONOAMINE RE-UPTAKE INHIBITOR 审中-公开
标题翻译：新型单胺再吸收抑制剂
公开(公告)号：WO2009118765A8
公开(公告)日：2010-09-10
申请号：PCT/IN2009000202
申请日：2009-03-27
申请人： PANACEA BIOTEC LTD , KESSAR SATINDER VIR , KULKARNI SHRINIVAS KRISHNARAO , JAIN RAJESH , TREHAN SANJAY , MAGADI SITARAM KUMAR , DAS JAGATTARAN , KAUR GURMEET , SINGH KAMAL NAIN , LATA SNEH , DHIR ASHISH
发明人： KESSAR SATINDER VIR , KULKARNI SHRINIVAS KRISHNARAO , JAIN RAJESH , TREHAN SANJAY , MAGADI SITARAM KUMAR , DAS JAGATTARAN , KAUR GURMEET , SINGH KAMAL NAIN , LATA SNEH , DHIR ASHISH
IPC分类号： C07D217/16 , C07D401/04 , C07D401/06 , C07D405/04 , C07D409/04 , C07D409/06 , C07D411/12 , C07D413/12
CPC分类号： C07D217/16 , C07D401/04 , C07D401/06 , C07D405/04 , C07D409/04 , C07D409/06 , C07D411/12 , C07D413/12
摘要： The present invention relates to novel compounds of Formula (I), their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of Formula (I), their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention further provides pharmaceutical compositions comprising compounds of Formula (I) and methods of treating or preventing one or more disorders of the central and/or peripheral nervous system that are responsive to inhibition of biogenic amines, in particular one or more, or any combination of serotonin, norepinephrine and dopamine.
摘要翻译：本发明涉及式（I）的新化合物，其药学上可接受的衍生物，互变异构形式，包括R和S异构体在内的立体异构体，多晶型物，前药，代谢物，盐或溶剂化物。本发明还涉及合成式（I）的新化合物，其药学上可接受的衍生物，互变异构形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂合物的方法。本发明进一步提供了包含式（I）化合物的药物组合物和治疗或预防中枢和/或外周神经系统的一种或多种病症的方法，所述病症对生物胺的抑制作出反应，特别是一种或多种血清素，去甲肾上腺素和多巴胺的组合。

8. 发明申请

WO2009116090A2 NOVEL ANTIMICROBIALS 审中-公开
标题翻译：新的抗生素
公开(公告)号：WO2009116090A2
公开(公告)日：2009-09-24
申请号：PCT/IN2009000184
申请日：2009-03-17
申请人： PANACEA BIOTEC LTD , JAIN RAJESH , TREHAN SANJAY , DAS JAGATTARAN , KANWAR SANDEEP , MAGADI SITARAM KUMAR
发明人： JAIN RAJESH , TREHAN SANJAY , DAS JAGATTARAN , KANWAR SANDEEP , MAGADI SITARAM KUMAR
IPC分类号： C07F9/40
CPC分类号： C07F9/657154 , C07F9/650958 , C07F9/65583 , C07F9/65586 , C07F9/65846
摘要： The present invention relates to novel phenyl oxazolidinone compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of Formula I and methods of treating or preventing conditions caused by microbial infections. The compounds of the present invention are effective against a number of aerobic and/or anaerobic Gram positive and/or Gram negative pathogens such as multi drug resistant Staphylococcus spp., Streptococcus spp., Enterococcus spp., Bacterioides spp., Clostridia spp., H. influenza, Moraxella Spp., as well as acid-fast organisms such as Mycobacterium tuberculosis and the like.
摘要翻译：本发明涉及式I的新的苯基恶唑烷酮化合物，其药学上可接受的衍生物，互变异构体，包括R和S异构体的立体异构体，多晶型物，前药，代谢物，盐或溶剂化物。本发明还涉及合成式I的新化合物，其药学上可接受的衍生物，互变异构形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂合物的方法。本发明还提供包含式I的新化合物和治疗或预防由微生物感染引起的病症的方法的药物组合物。本发明的化合物对多种需氧和/或厌氧革兰氏阳性和/或革兰氏阴性病原体有效，例如耐多药耐药的葡萄球菌属，链球菌属，肠球菌属，细菌属（Clostridia spp。）， H.流感，Moraxella Spp。以及耐酸生物如结核分枝杆菌等。

9. 发明申请

WO2005082892A3 TRIAZOLE COMPOUNDS AS ANTIBACTERIAL AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM 审中-公开
标题翻译：三唑化合物作为抗菌剂和含有它们的药物组合物
公开(公告)号：WO2005082892A3
公开(公告)日：2006-03-23
申请号：PCT/IB2005000343
申请日：2005-02-11
申请人： REDDYS LAB LTD DR , DAS JAGATTARAN , TAKHI MOHAMED , NATESAN SELVAKUMAR , TREHAN SANJAY , IQBAL JAVED , MAGADI SITARAM KUMAR , KANDEPU SREENIVAS
发明人： DAS JAGATTARAN , TAKHI MOHAMED , NATESAN SELVAKUMAR , TREHAN SANJAY , IQBAL JAVED , MAGADI SITARAM KUMAR , KANDEPU SREENIVAS
IPC分类号： C07D249/06 , C07D401/10 , C07D401/14 , C07D403/00 , C07D403/06 , C07D403/12 , C07D405/12 , C07D405/14 , C07D413/12
CPC分类号： C07D403/06 , C07D249/06 , C07D401/10 , C07D401/14 , C07D403/12 , C07D405/12 , C07D405/14 , C07D413/12
摘要： The present invention relates to novel triazole compounds of formula (I), where all symbols are as defined in the detailed description; their pharmaceutically acceptable salts their stereosiomers thereof, their prodrugs, their rotamers, their pharmaceutical compositions containing them. The present invention also relates to a process for the preparation of the above said novel compounds.
摘要翻译：本发明涉及新的式（I）三唑化合物，其中所有符号如详细描述中所定义; 其药学上可接受的盐，它们的立体异构体，它们的前药，它们的旋转异构体，它们含有它们的药物组合物。本发明还涉及制备上述新化合物的方法。

10. 发明申请

WO2004106329A2 NOVEL ANTIINFECTIVE COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS 审中-公开
标题翻译：新型抗生素化合物及其药物组合物
公开(公告)号：WO2004106329A2
公开(公告)日：2004-12-09
申请号：PCT/IB2004001811
申请日：2004-06-03
申请人： REDDYS LAB LTD DR , MOHAMED TAKHI , DAS JAGATTARAN , NATESAN SELVAKUMAR , TREHAN SANJAY , IQBAL JAVED , MAGADI SITARAM KUMAR
发明人： MOHAMED TAKHI , DAS JAGATTARAN , NATESAN SELVAKUMAR , TREHAN SANJAY , IQBAL JAVED , MAGADI SITARAM KUMAR
IPC分类号： A61P31/04 , C07D405/10 , C07D405/14 , C07D409/10 , C07D409/14 , C07D405/00
CPC分类号： C07D405/10 , C07D405/14 , C07D409/10 , C07D409/14
摘要： The present invention provides novel triazole compounds of formula (I), their pharmaceutically acceptable salts and their pharmaceutical compositions, where all symbols are as defined in the specification
摘要翻译：本发明提供新的式（I）三唑化合物，其药学上可接受的盐及其药物组合物，其中所有符号如说明书中所定义

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式